Loading...
Backblaze Inc (BLZE) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. While the company has shown some positive financial trends, such as revenue growth and improved gross margins, the negative technical indicators, mixed analyst sentiment, and lack of strong trading signals suggest that this is not an ideal entry point. The stock may be worth monitoring for future opportunities.
The technical indicators for BLZE are bearish. The MACD histogram is negative and expanding downward, the RSI is neutral at 35.13, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support levels are at 3.783 and 3.579, while resistance levels are at 4.444 and 4.648. The stock is trading below its pivot point of 4.114, indicating downward pressure.

Backblaze achieved free cash flow profitability and a 28% adjusted EBITDA margin in Q4
The launch of B2 Neo, a high-performance cloud storage solution for AI and machine learning workloads, positions the company well in a growing market.
Revenue increased by 11.77% YoY in Q4 2025.
Analysts have downgraded the stock or lowered price targets due to slower growth expectations and increased capital expenditures.
The company's net income dropped significantly by 62.35% YoY, and EPS fell by 70%.
Technical indicators and market sentiment are bearish, with no significant insider or hedge fund activity.
In Q4 2025, Backblaze reported revenue of $37.76 million, up 11.77% YoY, and achieved a gross margin of 62.37%, up 13.88% YoY. However, net income dropped to -$5.41 million (-62.35% YoY), and EPS fell to -$0.09 (-70% YoY). While the company achieved free cash flow profitability, the decline in net income and EPS is concerning.
Analyst sentiment is mixed. Craig-Hallum downgraded the stock to Hold with a $4.50 price target, citing concerns about slower growth and increased capital expenditures. Other firms like Oppenheimer, B. Riley, Lake Street, and Needham lowered their price targets but maintained Buy or Outperform ratings, highlighting strong EBITDA margins and operational improvements. However, the overall sentiment reflects caution due to slower growth and elongated deal timelines.